Avoid injecting into: Areas of broken, irritated, or sunburned skin Sites with bruising, swelling, or active infection Scar tissue or stretch marks , which may impair absorption Moles, warts, or skin lesions The area directly around the navel (within 5 cm) Waistbands or areas subject to friction from clothing Any site showing signs of lipohypertrophy (hardened, lumpy, or thickened skin) Mild injection site reactions such as temporary redness, minor swelling, or slight itching are relatively common with subcutaneous injectables and usually resolve within a few hours to days
The vesicular transporter STX11 governs ATGL-mediated hepatic lipolysis and lipophagy
TIGAR suppresses ER stress-induced neuronal injury through targeting ATF4 signaling in cerebral ischemia/reperfusion
More bacteria get to work on it
In exploratory research, retatrutide represents the most ambitious incretin agent currently available